During the past decade, Metropolitan Cardiology Consultants conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Metropolitan Cardiology Consultants" #1 sponsor was "Cardiovascular Systems Inc" with 1 trials, followed by "HealthCore-NERI" with 1 trials sponsored, "Hennepin Healthcare Research Institute" with 1 trials sponsored, "Inari Medical" with 1 trials sponsored and "Medtronic" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Metropolitan Cardiology Consultants" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Cardiovascular Research Foundation, New York" with 1 trials as a collaborator, "Guidant Corporation" with 1 trials as a collaborator and "Massachusetts General Hospital" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Metropolitan Cardiology Consultants" are "Heart Failure" (3 trials), "Acute Myocardial Infarction" (1 trials), "Bradycardia" (1 trials), "Coronary Artery Disease" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Metropolitan Cardiology Consultants" in a lesser frequency.

Most popular intervention types in "Metropolitan Cardiology Consultants" are "Device" (5 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Anticoagulation Agents" (1 trials), "Balloon" (1 trials), "EverFlex™ Self-Expanding Peripheral Stent System" (1 trials), "FlowTriever System" (1 trials) and "Implantable Hemodynamic Monitor (Chronicle® IHM), and IHM in combination with single chamber ICD (Chronicle ICD)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Metropolitan Cardiology Consultants" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Metropolitan Cardiology Consultants". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Metropolitan Cardiology Consultants, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Metropolitan Cardiology Consultants, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".